BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 119 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $151,800 | -24.0% | 60,000 | +100.0% | 0.16% | -34.7% |
| Q2 2023 | $199,800 | -15.3% | 30,000 | +50.0% | 0.24% | +75.4% |
| Q3 2022 | $236,000 | +156.5% | 20,000 | 0.0% | 0.14% | +160.4% |
| Q2 2022 | $92,000 | -78.0% | 20,000 | 0.0% | 0.05% | -79.8% |
| Q1 2022 | $418,000 | +2.7% | 20,000 | 0.0% | 0.26% | +17.0% |
| Q4 2021 | $407,000 | -32.9% | 20,000 | 0.0% | 0.22% | -26.1% |
| Q3 2021 | $607,000 | +4.5% | 20,000 | 0.0% | 0.30% | 0.0% |
| Q2 2021 | $581,000 | -32.7% | 20,000 | 0.0% | 0.30% | -46.1% |
| Q1 2021 | $863,000 | -6.6% | 20,000 | 0.0% | 0.56% | -10.8% |
| Q4 2020 | $924,000 | +6.6% | 20,000 | 0.0% | 0.63% | -11.3% |
| Q3 2020 | $867,000 | -19.0% | 20,000 | 0.0% | 0.71% | +14.9% |
| Q2 2020 | $1,070,000 | +139.4% | 20,000 | 0.0% | 0.62% | +47.1% |
| Q1 2020 | $447,000 | – | 20,000 | – | 0.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 60,000 | $151,800 | 0.16% |
| XTX Topco Ltd | 33,605 | $85,021 | 0.02% |
| Beacon Pointe Advisors, LLC | 301,735 | $763,390 | 0.01% |
| AllSquare Wealth Management LLC | 4,527 | $11,453 | 0.01% |
| Virtus ETF Advisers LLC | 4,646 | $11,754 | 0.01% |
| Y-Intercept (Hong Kong) Ltd | 27,553 | $69,709 | 0.01% |
| SeaCrest Wealth Management, LLC | 16,550 | $41,872 | 0.01% |
| Hennion & Walsh Asset Management, Inc. | 33,940 | $85,868 | 0.01% |
| Cutler Group LLC / CA | 4,000 | $50 | 0.01% |
| Capital Investment Advisory Services, LLC | 17,991 | $45,517 | 0.00% |